OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 43 filers reported holding OCUPHIRE PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $37,979 | +1695.7% | 8,751 | +1451.6% | 0.00% | – |
Q1 2023 | $2,115 | -29.5% | 564 | -66.8% | 0.00% | – |
Q3 2022 | $3,000 | -40.0% | 1,700 | -31.1% | 0.00% | – |
Q2 2022 | $5,000 | -73.7% | 2,466 | -57.1% | 0.00% | – |
Q1 2022 | $19,000 | -29.6% | 5,748 | -19.6% | 0.00% | – |
Q4 2021 | $27,000 | -34.1% | 7,145 | -8.8% | 0.00% | – |
Q3 2021 | $41,000 | +36.7% | 7,838 | +41.4% | 0.00% | – |
Q2 2021 | $30,000 | +172.7% | 5,542 | +206.2% | 0.00% | – |
Q1 2021 | $11,000 | – | 1,810 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Regency Capital Management Inc.\DE | 15,000 | $79,000 | 0.06% |
Ikarian Capital, LLC | 119,551 | $632,000 | 0.05% |
NORRIS PERNE & FRENCH LLP/MI | 78,909 | $417,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,445 | $124,000 | 0.02% |
Stokes Family Office, LLC | 12,120 | $64,000 | 0.01% |
MARSHALL WACE, LLP | 329,131 | $1,738,000 | 0.01% |
Cornerstone Capital, Inc. | 11,357 | $60,000 | 0.01% |
MCF Advisors LLC | 9,499 | $50,000 | 0.01% |
Cutler Group LLC / CA | 7,900 | $41,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 13,389 | $71,000 | 0.00% |